Koch, Kenneth L.
Parkman, Henry P.
Yates, Katherine P.
Van Natta, Mark L.
Grover, Madhusudan
Farrugia, Gianrico
Abell, Thomas L.
McCallum, Richard W.
Sarosiek, Irene
Kuo, Braden
Shulman, Robert J.
Miriel, Laura
Tonascia, James
Pasricha, Pankaj J.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK073974, U01DK073975, U24DK074008, U24DK074008, U24DK074008, U24DK074008, U01DK074007, U01DK074035, U01DK074035, U01DK112193, U01DK112194, U24DK074008, U24DK074008, U01DK073983)
NCATS (UL1TR000424)
Article History
Received: 5 February 2024
Accepted: 1 June 2024
First Online: 14 June 2024
Declarations
:
: Kenneth Koch is a shareholder in the 3CPM Company.
: NCT01696747.